Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

Hezode, C; Reau, N; Svarovskaia, ES; Doehle, BP; Shanmugam, R; Dvory-Sobol, H; Hedskog, C; McNally, J; Osinusi, A; Brainard, DM; Miller, MD; Mo, HM; Roberts, SK; O'Leary, JG; Shafran, SD; Zeuzem, S

Svarovskaia, ES (reprint author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.

JOURNAL OF HEPATOLOGY, 2018; 68 (5): 895

Abstract

Background & Aims: The fixed-dose combination of sofosbuvir/velpatasvir was highly efficacious in patients infected with genotype (GT) 1-6 hepatit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索